INmune Bio gets MHRA alignment for 2026 UK drug application

Go back to INmune Bio gets MHRA alignment for 2026 UK drug application
(NASDAQ: INMB) Delayed: 2.51 +0.07 (2.87%)
Previous Close $2.44    52 Week High
Open $2.44    52 Week Low
Day High $2.60    P/E N/A 
Day Low $2.41    EPS
Volume 493,793